News & Media, page-11

Global Cannabis Partnership Expands with Seven New Members
December 17, 2018

New members will adhere to the Responsible Cannabis Framework, a world first

SAINT JOHN, NB, Dec. 17, 2018 /PRNewswire/ - The Global Cannabis Partnership (GCP) is pleased to announce today the addition of seven new Members as it continues to grow internationally, bringing its total membership number to 31.

The GCP welcomes Cannvas MedTech Inc., Compass Cannabis Clinic / Starbuds Canada, Constance Therapeutics, MediPharm Labs Corp., Nutrasource Pharmaceutical & Neutraceutical Services, StrainprintTMTechnologies Ltd. and YSS by Solo.

"There's a growing interest in the GCP as more stakeholders recognize the importance and value of working together on industry-wide CSR policies and programs," says Kim Wilson, Executive Director. "At a time when everyone is learning as they go, and as this nascent industry develops around the world, now is the time to work collaboratively, share insights and knowledge, and set the bar for socially responsible practices."

The Member category is open to government agencies, licensed producers, national associations, industry partners and community groups from the global cannabis industry. Neither an advocacy nor a lobby group, the GCP represents a cross-section of organizations that play – or will play – a role in the legal, adult-use recreational cannabis supply chain. The GCP mirrors successful initiatives in other industry sectors, such as alcohol, gaming, pharmaceuticals and forestry.

The GCP is working with two of its Founding Members, PwC Canada and McCarthy Tétrault, to establish itself as a non-profit legal entity, and finalize a governance structure led by a board of directors. The development of the Responsible Cannabis Framework, a worldwide social responsibility standard, is near completion and will be launched in 2019.


About the Global Cannabis Partnership:
Founded by Revolution Strategy, the Global Cannabis Partnership (GCP) is a collaboration of leaders in the government-sanctioned, adult-use recreational cannabis industry. With representation from government, private-sector and affiliate organizations, the GCP is creating an international standard for the safe and responsible production, distribution and consumption of legal recreational cannabis. One of its first activities will be to create a Responsible Cannabis Framework, to shape the face of social responsibility in the recreational cannabis industry. For more information, visit globalcannabispartnership.com.

New GCP Member Quotes:

MediPharm Labs Corp.:"We're pleased to join this industry-leading organization that is helping to connect producers and researchers around the world. We look forward to being at the table to uphold an elevated ethos for all Members and to educate the public about beneficial, responsible use," says Sybil Taylor, Chief Marketing Officer of MediPharm Labs Corp.

Additional New GCP Member Information:

MediPharm Labs Corp. has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the ACMPR without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for advanced derivative products. MediPharm Labs has invested in an expert research-driven team, state-of-the-art technology, downstream extraction methodologies and purpose-built facilities to create pure, safe and precisely-dosed cannabis products for global patients and consumers. MediPharm Labs was recently named Start-up of the Year at the Canadian Cannabis Awards.

View original content to download multimedia:http://www.prnewswire.com/news-rele...expands-with-seven-new-members-300767411.html